Skip to content

PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease

PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02263430
Enrollment
8
Registered
2014-10-13
Start date
2016-12-31
Completion date
2018-12-31
Last updated
2016-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington's Disease

Brief summary

Deep Brain Stimulation (DBS) of the Globus pallidus internus(GPi) is useful in the treatment of different forms of chorea, including Huntington's disease (HD).

Interventions

DEVICEDeep Brain Stimulation

Sponsors

Beijing Tiantan Hospital
CollaboratorOTHER
Beijing Pins Medical Co., Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject clinically symptomatic and genetically confirmed Huntington Disease (number of CAG repeats\>= 36) 2. Moderate stage of the disease (UHDRS motor\>= 30) 3. Predominant movement disorder 4. Compliance of the patient, stable cognition during a 6 months phase prior to inclusion (Mattis Dementia Rating Scales(MDS)\>/= 120) 5. Signed informed consent.

Exclusion criteria

1. Patients with hearing impairment; 2. Failures of important organs and in severe conditions; 3. Be reluctant or disabled to receive neuropsychological assessments; 4. Participate in other clinical trial; 5. Has a life expectancy of \< 1 year. 6. The investigator and/or enrollment review committee, would preclude participation in the study.

Design outcomes

Primary

MeasureTime frame
Unified Huntington's Disease Rating Scale(UHDRS)12 month

Contacts

Primary ContactJia Fumin, PhD
pins_medical@163.com010-59361265

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026